[1]
Merola, J.F., Conrad, C., Hampton, P. , Lambert, J., Gottlieb, A.B., Tilt, N. , Cross, N., Wiegratz, S. and Gooderham, M. 2024. Bimekizumab 3-year Efficacy in High-Impact Areas in Moderate to Severe Plaque Psoriasis: Pooled Results from Five Phase 3/3b Trials. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s304. DOI:https://doi.org/10.25251/skin.8.supp.304.